IBDEI1MH ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29176,0)
 ;;=682.2^^183^1854^33
 ;;^UTILITY(U,$J,358.3,29176,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29176,1,4,0)
 ;;=4^Cellulitis of Trunk
 ;;^UTILITY(U,$J,358.3,29176,1,5,0)
 ;;=5^682.2
 ;;^UTILITY(U,$J,358.3,29176,2)
 ;;=^271890
 ;;^UTILITY(U,$J,358.3,29177,0)
 ;;=414.8^^183^1854^34
 ;;^UTILITY(U,$J,358.3,29177,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29177,1,4,0)
 ;;=4^Chr Ischemic Hrt Disease NEC
 ;;^UTILITY(U,$J,358.3,29177,1,5,0)
 ;;=5^414.8
 ;;^UTILITY(U,$J,358.3,29177,2)
 ;;=^269680
 ;;^UTILITY(U,$J,358.3,29178,0)
 ;;=707.10^^183^1854^91
 ;;^UTILITY(U,$J,358.3,29178,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29178,1,4,0)
 ;;=4^Ulcer of Lower Limb,Unspec
 ;;^UTILITY(U,$J,358.3,29178,1,5,0)
 ;;=5^707.10
 ;;^UTILITY(U,$J,358.3,29178,2)
 ;;=^322142
 ;;^UTILITY(U,$J,358.3,29179,0)
 ;;=414.01^^183^1854^35
 ;;^UTILITY(U,$J,358.3,29179,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29179,1,4,0)
 ;;=4^Cor Atheroscl Natv C Vsl
 ;;^UTILITY(U,$J,358.3,29179,1,5,0)
 ;;=5^414.01
 ;;^UTILITY(U,$J,358.3,29179,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,29180,0)
 ;;=446.5^^183^1854^44
 ;;^UTILITY(U,$J,358.3,29180,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29180,1,4,0)
 ;;=4^Giant Cell Arteritis
 ;;^UTILITY(U,$J,358.3,29180,1,5,0)
 ;;=5^446.5
 ;;^UTILITY(U,$J,358.3,29180,2)
 ;;=^117658
 ;;^UTILITY(U,$J,358.3,29181,0)
 ;;=446.21^^183^1854^45
 ;;^UTILITY(U,$J,358.3,29181,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29181,1,4,0)
 ;;=4^Goodpasture's Syndrome
 ;;^UTILITY(U,$J,358.3,29181,1,5,0)
 ;;=5^446.21
 ;;^UTILITY(U,$J,358.3,29181,2)
 ;;=^52601
 ;;^UTILITY(U,$J,358.3,29182,0)
 ;;=V58.67^^183^1854^53
 ;;^UTILITY(U,$J,358.3,29182,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29182,1,4,0)
 ;;=4^Long-Term Use of Insulin
 ;;^UTILITY(U,$J,358.3,29182,1,5,0)
 ;;=5^V58.67
 ;;^UTILITY(U,$J,358.3,29182,2)
 ;;=^331585
 ;;^UTILITY(U,$J,358.3,29183,0)
 ;;=446.1^^183^1854^57
 ;;^UTILITY(U,$J,358.3,29183,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29183,1,4,0)
 ;;=4^Mucocutan Lymph Node Syndrome
 ;;^UTILITY(U,$J,358.3,29183,1,5,0)
 ;;=5^446.1
 ;;^UTILITY(U,$J,358.3,29183,2)
 ;;=^79494
 ;;^UTILITY(U,$J,358.3,29184,0)
 ;;=433.30^^183^1854^60
 ;;^UTILITY(U,$J,358.3,29184,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29184,1,4,0)
 ;;=4^Occl/Sten Mult/Bil Art w/o CRB
 ;;^UTILITY(U,$J,358.3,29184,1,5,0)
 ;;=5^433.30
 ;;^UTILITY(U,$J,358.3,29184,2)
 ;;=^295803
 ;;^UTILITY(U,$J,358.3,29185,0)
 ;;=451.83^^183^1854^66
 ;;^UTILITY(U,$J,358.3,29185,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29185,1,4,0)
 ;;=4^Phl/Thrombophl Deep Veins,Upper Extrem
 ;;^UTILITY(U,$J,358.3,29185,1,5,0)
 ;;=5^451.83
 ;;^UTILITY(U,$J,358.3,29185,2)
 ;;=^295745
 ;;^UTILITY(U,$J,358.3,29186,0)
 ;;=451.82^^183^1854^67
 ;;^UTILITY(U,$J,358.3,29186,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29186,1,4,0)
 ;;=4^Phl/Thrombophl Sup Veins,Upper Extrem
 ;;^UTILITY(U,$J,358.3,29186,1,5,0)
 ;;=5^451.82
 ;;^UTILITY(U,$J,358.3,29186,2)
 ;;=^295744
 ;;^UTILITY(U,$J,358.3,29187,0)
 ;;=451.84^^183^1854^68
 ;;^UTILITY(U,$J,358.3,29187,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29187,1,4,0)
 ;;=4^Phl/Thrombophl,Upper Extrem,Unspec
 ;;^UTILITY(U,$J,358.3,29187,1,5,0)
 ;;=5^451.84
 ;;^UTILITY(U,$J,358.3,29187,2)
 ;;=^295746
 ;;^UTILITY(U,$J,358.3,29188,0)
 ;;=446.0^^183^1854^70
 ;;^UTILITY(U,$J,358.3,29188,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,29188,1,4,0)
 ;;=4^Polyartertitis Nodosa
 ;;^UTILITY(U,$J,358.3,29188,1,5,0)
 ;;=5^446.0
 ;;^UTILITY(U,$J,358.3,29188,2)
 ;;=^91874
 ;;^UTILITY(U,$J,358.3,29189,0)
 ;;=V81.0^^183^1854^75
 ;;^UTILITY(U,$J,358.3,29189,1,0)
 ;;=^358.31IA^5^2
